Skip to content

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Pharmaceuticals

Daewoong Pharmaceutical’s Inabogliflozin no drug interference

Daewoong Pharmaceutical’s Inabogliflozin no drug interference

Hanmi Pharmaceutical’s Rolontis became the 33rd Korean drug

Hanmi Pharmaceutical’s Rolontis became the 33rd Korean drug

Daewon Pharmaceutical’s “Governor’s Potagel Suspension, Continues to Be No.

Daewon Pharmaceutical’s “Governor’s Potagel Suspension, Continues to Be No.

Daewon Pharmaceutical’s Governor’s Potagel Suspension, No. 1 Market Share in January

Daewon Pharmaceutical’s Governor’s Potagel Suspension, No. 1 Market Share in January

Non-conservative pharmaceuticals, illegal manufacturing of pharmaceuticals detected…  Wavelength spread to manufacturing plants nationwide

Non-conservative pharmaceuticals, illegal manufacturing of pharmaceuticals detected… Wavelength spread to manufacturing plants nationwide

MEDI:GATE NEWS Daewoong Pharmaceutical’s partner, begins global phase 2 clinical trial for botulinum toxin migraine treatment

MEDI:GATE NEWS Daewoong Pharmaceutical’s partner, begins global phase 2 clinical trial for botulinum toxin migraine treatment

Myeongin Pharmaceuticals, full-fledged targeting the Japanese drug substance market

Myeongin Pharmaceuticals, full-fledged targeting the Japanese drug substance market

Ilyang Pharmaceuticals failed phase 3 clinical trial for corona treatment in Russia

Ilyang Pharmaceuticals failed phase 3 clinical trial for corona treatment in Russia

Launched Hanmi Pharmaceutical’s partner organon’Rosujet’ in Mexico

Launched Hanmi Pharmaceutical’s partner organon’Rosujet’ in Mexico

MEDI:GATE NEWS Daewoong Pharmaceutical’s patent lawsuit against generic sales…imposed a fine of 2.297 billion won

MEDI:GATE NEWS Daewoong Pharmaceutical’s patent lawsuit against generic sales…imposed a fine of 2.297 billion won

Hanmi Pharmaceutical’s new anticancer drug’Oraxol’ is not approved in the US…  “Request for supplementary materials”

Hanmi Pharmaceutical’s new anticancer drug’Oraxol’ is not approved in the US… “Request for supplementary materials”

[특징주] Ildong Pharmaceutical’s success in the production of failed Alzheimer’s treatments in Switzerland and China is on the rise

[특징주] Ildong Pharmaceutical’s success in the production of failed Alzheimer’s treatments in Switzerland and China is on the rise

Older posts
Newer posts
← Previous Page1 Page2 Page3 … Page6 Next →

footer

  • Contact Us
  • Sitemap
  • News-Sitemap
© 2025 Aju.News/en